GINA LEWIS: Open Payments
NPI 1831447820 · SPRINGFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 23 payments from 11 companies in 2025. Trend: 2023 $391 · 2024 $405 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| COLOPLAST CORP | 6 | $122 |
| Sumitomo Pharma America, Inc. | 4 | $109 |
| ABBVIE INC. | 1 | $94 |
| Ferring Pharmaceuticals Inc. | 3 | $54 |
| Endo USA, Inc. | 2 | $52 |
| PFIZER INC. | 2 | $50 |
| Boston Scientific Corporation | 1 | $48 |
| UROGEN PHARMA, INC. | 1 | $26 |
| IMMUNITYBIO, INC. | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $22 |
Products named: Luja Coude, BOTOX, ORGOVYX, ADSTILADRIN, AVEED, XTANDI, AMS 700, GEMTESA.
Industry payments across MA — which companies pay providers there.
